Home
Chad M. Robins, CEO and Chairman: Adaptive Biotechnologies ADPT Sell · Filed 25/02/18
Trade details
- Type
- Insider sale
- Amount
- $1,794,860
- Shares · price
- 211,160 sh · $8.50 a share
- Held after
- 2,576,701 sh
- Trade date
- 25/02/18
- Filed
- 25/02/18
- Days to filing
- 0 days
Sold 7.6% of holdings
- Share of holding sold
- 7.6%
Adaptive Biotechnologies trades, last 26 weeks
What else happened in Adaptive Biotechnologies around then
Filed or reported within 30 days of the trade day · 25/01/19~25/03/20Chad M. Robins's recent trades
- Chad M. Robins
Planned saleAdaptive Biotechnologies
Planned saleAdaptive Biotechnologies
ADPT
$6.8M
278,676 sh
$6.8M
Filed 08/18
Traded 08/18
- Chad M. Robins
Planned saleAdaptive Biotechnologies
Planned saleAdaptive Biotechnologies
ADPT
$8M
321,324 sh
$8M
Filed 08/17
Traded 08/17
- Chad M. Robins
Sell10b5-1 planAdaptive Biotechnologies
Sell10b5-1 planAdaptive Biotechnologies
ADPT
$1.2M
83,332 sh
$1.2M
Filed 04/08
Traded 04/06
- Chad M. Robins
Sell10b5-1 planAdaptive Biotechnologies
Sell10b5-1 planAdaptive Biotechnologies
ADPT
$566K
37,263 sh
$566K
Filed 04/08
Traded 04/08
- Chad M. Robins
Planned sale10b5-1 planAdaptive Biotechnologies
Planned sale10b5-1 planAdaptive Biotechnologies
ADPT
$553K
37,263 sh
$553K
Filed 04/08
Traded 04/08